Samo prijavljeni korisnici mogu pregledati cijeli sadržaj.
ZAGREB, Sept 21 (Hina) - Pliva is going to sell its Pliva-Lachema's
diagnostic business and to close down other manufacturing activities
at Pliva-Lachema in Brno, the Czech Republic, by the end of this year,
following an agreement which was reached after its integration with
Teva, that is the acquisition by Teva of Barr/Pliva, the Croatian drug
manufacturer said in a statement released on the Zagreb Stock Exchange
on Monday.